期刊文献+

拉科酰胺的合成工艺改进 被引量:1

Process Optimization for the Synthesis of Lacosamide
下载PDF
导出
摘要 以丙烯酸为起始原料与苄胺缩合得到N-苄基丙烯酰胺(4),收率由70%提高至83%,4与NBS通过烯烃双键双官能团化用二氯甲烷和甲醇混合溶剂得到N-苄基-3-甲氧基-2-溴丙酰胺(5)收率由70%提高至76%,5与叠氮钠反应得到N-苄基-2-叠氮基-3-甲氧基丙酰胺(6),6经钯碳加氢得到2-氨基-N-苄基-3-甲氧基丙酰胺(7)两步收率达到83.6%,7经乙酰化得到2-乙酰胺基-3-甲氧基-N-苄基丙酰胺(8),8经SFC色谱柱手性拆分得到拉科酰胺(1)(拆分收率47.6%),总收率22.8%(以2计)。拉科酰胺结构经~1CNMR、~1HNMR及MS确证。 N-beuzyl -acrylamide (4) was prepared by acrylic acid and benzylamine, with a yield of 83 %. After a difunctionalization of C-C double Bond, N-Benzyl-3-methoxy-2-bromopropanamide (5) was obtained in DCM and MeOH with a yield of 76 %. Then 5 was reacted with sodium azide to give N-benzyl-2-azido-3-methoxypropanamide (6), 6 was reduced with Pd/C to give 2 -Amino-N-benzyl-3-methoxypropionamide (7) with two steps yield of 83 %. 2-acetamido-3-methoxy-N-benzylpropanamide (8) was obtained by 7 with acetic anhydride. Then the target compound Lacosamide (1) was prepared by SFC to chiral separate 8, (separation yield 47.6 %).The total yield was 22.7 % (calculated as 2). The target structure was confirmed by IHNMR, ICNMR and MS (ESI).
作者 纪忠兆 王桂艳 Ji Zhongzhao;Wang Guiyan(College of Pharmacy, Jiamusi University, Jiamusi 154007, China)
出处 《广东化工》 CAS 2018年第8期31-32,共2页 Guangdong Chemical Industry
关键词 拉科酰胺 抗癫痫 酰胺化 药物合成 Lacosamide anticonvulsantdrug amidation drug synthesis
  • 相关文献

参考文献5

二级参考文献41

  • 1CHOI D, STABLES, J P, KHON H. Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropi- on-amide derivatives [ J ]. J Med Chem, 1996,39 ( 9 ) : 1907-1916.
  • 2Research Corporation Tech , KHON H , ANDURKAR S V. Anticonvulsant enantiomeric amino acid derivatives: US ,6048899 A[ P]. 2000 - 04 - 11
  • 3Schwarz Pharma A G,RIEDNER J. Improved synthesis scheme for lacosamide: EP, 1642889 A1 [ P]. 2006 - 04 - 05.
  • 4Beydoun A, DSouza J, Hebert D,et al. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures[J]. Expert Rev Neurother, 2009,9( 1 ) :33-42.
  • 5Kellinghaus C. Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety [ J]. Ther Clin Risk Manag, 2009,5:757-766.
  • 6Halasz P, Kalviainen R, Mazurkiewicz-Beldzinska M, et al. Adjunctive lacosamide for partial - onset seizures: Efficacy and safety results from a randomized controlled trial[ J ]. Epilepsia, 2009, 50(3):443-453.
  • 7Ben-Menachem E, Biton V, Jatuzis D, et al. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures [ J ]. Epilepsia, 2007, 48 ( 7 ) : 1308- 1317.
  • 8Beyreuther BK, Geis C, Stohr T, et al. Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF [ J ]. Neuropharmacology JT-Neuropharmacology. 2007, 52(5) :1312-1327.
  • 9Halford JJ, Lapointe M. Clinical perspectives on lacosamide [ J]. Epilepsy Curr JT-Epilepsy currents ! American Epilepsy Society,2009,9( 1 ) : 1-9.
  • 10Wymer JP, Simpson J, Sen D,et al. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double- blind placebo-controlled trial of fixed-dose regimens [ J ]. Clin J Pain JT- The Clinical journal of pain, 2009,25 (5) :376-385.

共引文献17

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部